經導管心臟節律器市場規模、佔有率和成長分析：按產品類型、適應症、最終用戶、手術類型和地區分類－產業預測，2026-2033年

2024 年全球經導管心臟節律器市場價值為 13.6 億美元，預計到 2025 年將成長至 15.5 億美元，到 2033 年將成長至 45 億美元，在預測期（2026-2033 年）內複合年成長率為 14.2%。

全球經導管心臟節律器市場正經歷顯著成長，這主要得益於人們對微創電生理手術需求的不斷成長，此類手術既能提高患者舒適度，又能最大限度地降低手術風險。以領先企業創新產品為代表的無導線心律調節器，在提供與傳統囊袋式心律調節器相當的療效的同時，避免了相關併發症。經導管植入術的推薦，尤其適用於老年患者和接受抗凝血治療的患者，進一步推動了市場擴張。此外，電池技術的進步已將心律調節器的使用壽命延長至八年以上，從而減少了更換頻率，降低了成本，並降低了感染風險。歐洲心臟衰竭診所的證據表明，無導線系統可減少術後併發症，這促使保險公司更傾向於選擇此類方案。這一趨勢正在刺激製造商的技術創新，擴大這些心律調節器的適用人群，並形成競爭格局，從而加速其在全球範圍內的普及應用。

全球經導管心臟節律器市場按產品類型、適應症、最終用戶、手術方式和地區進行細分。依產品類型分類，分為單心室無導線心律調節器和雙心室無導線心律調節器。依適應症分類，分為心搏過緩、房室傳導阻滯、病竇症候群及其他心率。依最終用戶分類，分為醫院、專科心臟醫療中心和門診手術中心。依手術方式分類，分為首次植入和更換。按地區分類，分為北美、歐洲、亞太、拉丁美洲以及中東和非洲。

全球經導管心臟節律器市場的成長要素

隨著老年人口的不斷成長，與老齡化相關的傳導障礙日益常見，而患者往往伴隨其他健康問題，限制了手術干預，導致對有效心率節律管理方案的需求顯著增加。經導管心臟節律器提供了一種微創植入選擇。這符合臨床對降低手術風險、縮短住院時間和恢復時間的需求，因此在日益成長的老年人群中得到廣泛應用。此外，醫療專業人員也非常欣賞能夠根據個別解剖因素客製化設備的特性，這進一步加強了以患者為中心的照護策略，並有助於改善長期健康狀況。

全球經導管心臟節律器市場的限制因素

經導管心臟心律調節器高成本，這源自於其先進的製造流程和個人化的輸送系統，對許多醫療機構，尤其是預算有限的機構而言，構成了巨大的經濟障礙。此外，健保報銷政策往往無法跟上科技的快速發展，導致保險覆蓋不足或核准標準過於嚴格。因此，許多醫院可能會選擇報銷更容易的傳統外科手術治療，從而延緩這些創新設備的普及，最終阻礙市場成長。這項經濟挑戰限制了經導管解決方案的廣泛應用，並阻礙了其在各種患者照護環境中的整合。

全球經導管心臟節律器市場趨勢

全球經導管心臟節律器市場正經歷著向微創治療的顯著轉變，醫療專業人員越來越傾向於選擇經導管心律調節器植入術而非傳統外科手術。這項轉變源自於手術的諸多優勢，包括減輕病患負擔、縮短住院時間和加速復原。導管設計、導線技術和影像技術的不斷進步進一步提升了手術的精準性和安全性，增強了臨床醫師的信心。因此，隨著轉診模式的改變和適用患者範圍的擴大，微創解決方案已穩固確立其在現代心臟節律管理中的重要地位，並改善了全球患者的長期治療效果。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球經導管心臟節律器市場規模：依產品類型分類

• 單腔無鉛紙帶製作器
• 雙腔無引線空間製造器

全球經導管心臟節律器市場規模：依適應症分類

• 心搏過緩
• 房室傳導阻滯
• 病竇症候群
• 其他心律不整

全球經導管心臟節律器市場規模：依最終用戶分類

• 醫院
• 心臟醫療中心
• 門診手術中心

全球經導管心臟節律器市場規模：依手術類型分類

• 初始種植
• 置換手術

全球經導管心臟節律器市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Medtronic plc
• Abbott Laboratories
• Boston Scientific Corporation
• Biotronik SE & Co. KG
• MicroPort Scientific Corporation
• Lepu Medical Technology（Beijing）Co., Ltd.
• Osypka AG
• Shenzhen Qinming Medical Devices Co., Ltd.
• Shree Pacetronix Ltd.
• Medico SpA
• Sorin Group Italia Srl
• Integer Holdings Corporation
• Cook Medical LLC
• Meril Life Sciences Pvt. Ltd.
• Teleflex Incorporated
• Edwards Lifesciences Corporation
• WL Gore & Associates, Inc.
• Terumo Corporation
• B. Braun SE
• Asahi Intecc Co., Ltd.

結論與建議

Global Transcatheter Cardiac Pacemaker Market size was valued at USD 1.36 Billion in 2024 and is poised to grow from USD 1.55 Billion in 2025 to USD 4.5 Billion by 2033, growing at a CAGR of 14.2% during the forecast period (2026-2033).

The global transcatheter cardiac pacemaker market is witnessing significant growth driven by the increasing preference for minimally invasive electrophysiology procedures that enhance patient comfort while minimizing surgical risks. Lead-less devices, exemplified by innovations from prominent companies, have shown comparable pacing effectiveness without the complications associated with traditional pocket-based systems. The endorsement of transcatheter implants, particularly for elderly and anticoagulated patients, is expanding the market reach. Furthermore, advancements in battery technology enabling device longevity beyond eight years reduce replacement frequency, lower costs, and mitigate infection risks. Evidence from European heart failure clinics highlights the reduced post-operative complications with lead-less systems, prompting insurers to favor these options. This trend encourages manufacturers to innovate, leading to greater eligibility for patients and a competitive market landscape that accelerates adoption globally.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Transcatheter Cardiac Pacemaker market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Transcatheter Cardiac Pacemaker Market Segments Analysis

The global transcatheter cardiac pacemaker market is segmented by product type, indication, end user, procedure type and region. Based on product type, the market is segmented into Single-Chamber Leadless Pacemakers and Dual-Chamber Leadless Pacemakers. Based on indication, the market is segmented into Bradycardia, Atrioventricular Block, Sick Sinus Syndrome and Other Cardiac Rhythm Disorders. Based on end user, the market is segmented into Hospitals, Cardiac Specialty Centers and Ambulatory Surgical Centers. Based on procedure type, the market is segmented into Primary Implantation and Replacement Procedures. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Transcatheter Cardiac Pacemaker Market

The increasing number of older adults has significantly amplified the need for effective rhythm management solutions, as age-related conduction disorders become more common and patients frequently have additional health issues that restrict surgical interventions. Transcatheter cardiac pacemakers provide a minimally invasive implantation option, which resonates with clinical preferences for lower procedural risks, shorter hospital stays, and faster recovery times, facilitating their widespread acceptance among this growing demographic. Furthermore, healthcare professionals appreciate the capacity to customize device selection based on unique anatomical factors, which further enhances patient-centered care strategies and contributes to improved long-term health outcomes.

Restraints in the Global Transcatheter Cardiac Pacemaker Market

The high cost associated with transcatheter cardiac pacemakers, stemming from advanced manufacturing techniques and tailored delivery systems, creates significant financial obstacles for numerous healthcare providers, especially in budget-sensitive settings. Furthermore, reimbursement policies frequently do not keep pace with the rapid evolution of technology, leading to inadequate coverage or restrictive approval criteria. As a result, many hospitals may choose to delay the adoption of these innovative devices in favor of more traditional surgical options that offer easier reimbursement, ultimately hindering the market's growth. This economic challenge restricts the broader implementation of transcatheter solutions, impeding their integration into various patient care settings.

Market Trends of the Global Transcatheter Cardiac Pacemaker Market

The Global Transcatheter Cardiac Pacemaker market is witnessing a significant trend toward minimally invasive treatments, as healthcare providers increasingly favor transcatheter pacemaker implantation over traditional surgical methods. This shift is fueled by the numerous benefits of the procedure, including decreased trauma, shorter hospital stays, and expedited recovery for patients. Continuous advancements in catheter design, lead technology, and imaging techniques have further improved procedural precision and safety, fostering greater clinician confidence. Consequently, evolving referral patterns are broadening the patient eligibility spectrum, solidifying minimally invasive solutions as essential components in modern cardiac rhythm management for enhanced long-term patient outcomes worldwide.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Transcatheter Cardiac Pacemaker Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Single-Chamber Leadless Pacemakers
• Dual-Chamber Leadless Pacemakers

Global Transcatheter Cardiac Pacemaker Market Size by Indication & CAGR (2026-2033)

• Market Overview
• Bradycardia
• Atrioventricular Block
• Sick Sinus Syndrome
• Other Cardiac Rhythm Disorders

Global Transcatheter Cardiac Pacemaker Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Cardiac Specialty Centers
• Ambulatory Surgical Centers

Global Transcatheter Cardiac Pacemaker Market Size by Procedure Type & CAGR (2026-2033)

• Market Overview
• Primary Implantation
• Replacement Procedures

Global Transcatheter Cardiac Pacemaker Market Size & CAGR (2026-2033)

• North America (Product Type, Indication, End User, Procedure Type)
  • US
  • Canada
• Europe (Product Type, Indication, End User, Procedure Type)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Indication, End User, Procedure Type)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Indication, End User, Procedure Type)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Indication, End User, Procedure Type)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik SE & Co. KG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lepu Medical Technology (Beijing) Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Osypka AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shenzhen Qinming Medical Devices Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shree Pacetronix Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medico S.p.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sorin Group Italia S.r.l.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integer Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meril Life Sciences Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• W. L. Gore & Associates, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Intecc Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations